172 related articles for article (PubMed ID: 21623205)
61. Analysis of performance characteristics of five cell cycle-related immunohistochemical markers and human papillomavirus genotyping in the diagnosis of cervical squamous cell carcinoma precursor lesions.
Conesa-Zamora P; Trujillo-Santos J; Orantes-Casado FJ; Ortiz-Reina S; Torres-Moreno D; Pérez-Guillermo M
Anal Quant Cytol Histol; 2012 Feb; 34(1):49-55. PubMed ID: 22590819
[TBL] [Abstract][Full Text] [Related]
62. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.
Murphy N; Heffron CC; King B; Ganuguapati UG; Ring M; McGuinness E; Sheils O; O'Leary JJ
Virchows Arch; 2004 Dec; 445(6):610-5. PubMed ID: 15378361
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic value of p16 and Ki-67 expression in cervical glandular intraepithelial disease: A review.
Pereira Pinto P; Zanine RM
Ann Diagn Pathol; 2023 Feb; 62():152054. PubMed ID: 36396551
[TBL] [Abstract][Full Text] [Related]
64. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract][Full Text] [Related]
65. Expression of the Immunohistochemical Markers p16 and Ki-67 and Their Usefulness in the Diagnosis of Cervical Intraepithelial Neoplasms.
de Melo FL; Lancellotti CL; da Silva MA
Rev Bras Ginecol Obstet; 2016 Feb; 38(2):82-7. PubMed ID: 26883858
[TBL] [Abstract][Full Text] [Related]
66. [Expression of ProEXC, p16 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry: diagnostic and clinical significance].
Yang QC; Liu HB; Zhu Y; Zhang XJ; Shen Y; Ji XH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):405-7. PubMed ID: 22932410
[No Abstract] [Full Text] [Related]
67. A cocktail of MCM2 and TOP2A, p16INK4a and Ki-67 as biomarkers for the improved diagnosis of cervical intraepithelial lesion.
Yang QC; Zhu Y; Liou HB; Zhang XJ; Shen Y; Ji XH
Pol J Pathol; 2013 Apr; 64(1):21-7. PubMed ID: 23625596
[TBL] [Abstract][Full Text] [Related]
68. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
70. Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
Liang L; Zheng W; Liu J; Liang SX
Arch Pathol Lab Med; 2016 Feb; 140(2):148-52. PubMed ID: 26910219
[TBL] [Abstract][Full Text] [Related]
71. [Differential diagnosis of precancerous and regenerative changes in the epithelium of the cervix uteri, by applying an immunohistochemical study].
Danilova NV; Andreeva IuIu; Mal'kov PG
Arkh Patol; 2011; 73(2):10-4. PubMed ID: 21695981
[TBL] [Abstract][Full Text] [Related]
72. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
73. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
Little L; Stewart CJ
Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
[TBL] [Abstract][Full Text] [Related]
74. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
[TBL] [Abstract][Full Text] [Related]
75. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.
Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM
Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508
[No Abstract] [Full Text] [Related]
76. Exploiting the residual of cervical thin layer brush samples through cytohistology in cases with invasive carcinoma with application of antibodies.
Risse EK; Ouwerkerk-Noordam E; Meijer-Marres EM; Boon ME
Acta Cytol; 2010; 54(2):175-82. PubMed ID: 20391974
[TBL] [Abstract][Full Text] [Related]
77. A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
Pavlakis K; Messini I; Yiannou P; Chrissanthakis D; Papaspyrou I; Panoskaltsis T; Stathopoulos EN
Gynecol Oncol; 2010 Mar; 116(3):468-72. PubMed ID: 19913894
[TBL] [Abstract][Full Text] [Related]
78. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions.
El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS
Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084
[TBL] [Abstract][Full Text] [Related]
79. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.
Negri G; Vittadello F; Romano F; Kasal A; Rivasi F; Girlando S; Mian C; Egarter-Vigl E
Virchows Arch; 2004 Dec; 445(6):616-20. PubMed ID: 15480761
[TBL] [Abstract][Full Text] [Related]
80. [Value of ER, VIM, CEA and p16 detection in the diagnosis and differential diagnosis of primary endocervical and endometrial adenocarcinomas].
Hu WW; Tao JH; Li GM; Xu X; Yang XM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):526-8, 531. PubMed ID: 20335127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
